Just more than a quarter of people have heard of the term 'personalized medicine,' according to a recent survey conducted by GfK Bridgehead, a market research firm. Additionally, as Ed Silverman at Pharmalot notes, many people think that such tailored treatments will lead to a rise in healthcare costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The Lobby Effect

CRO Future

Sorta Safe and Secure

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.